What is Gator Bio?
Gator Bio is a specialized entity focused on Biolayer Interferometry (BLI) technology, offering sophisticated, label-free solutions for real-time biomolecular analysis. Its product portfolio encompasses a range of BLI instruments, biosensors, and software, critically supporting applications in drug discovery, vaccine development, and antibody characterization. By targeting clients within the biopharma, academic, and diagnostics sectors, Gator Bio endeavors to expedite research and discovery workflows. The company also provides bespoke biosensor solutions, meticulously tailored to meet unique research requirements.
How much funding has Gator Bio raised?
Gator Bio has raised a total of $931K across 2 funding rounds:
Debt
$350K
Debt
$581K
Debt (2020): $350K with participation from PPP
Debt (2021): $581K led by PPP
What's next for Gator Bio?
The substantial enterprise-level funding and recent strategic investment position Gator Bio for accelerated growth and market expansion. This capital infusion is expected to fuel further innovation in BLI technology, enhance product development, and broaden the company's reach within the biopharmaceutical and diagnostic industries. Gator Bio's focus on label-free, real-time analysis aligns with the increasing demand for efficient and accurate biomolecular characterization, suggesting a strong future outlook as it continues to support critical research and development initiatives.
See full Gator Bio company page
